TRPC5 Channel Inhibition Protects Podocytes in Puromycin-Aminonucleoside Induced Nephrosis Models
Open Access
- 21 September 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
Abstract
Podocyte injury and the appearance of proteinuria are key features of several progressive kidney diseases. Genetic deletion or selective inhibition of TRPC5 channels with small-molecule inhibitors protects podocytes in rodent models of kidney disease, but less is known about the human relevance and translatability of TRPC5 inhibition. Here, we investigate the effect of TRPC5 inhibition in puromycin aminonucleoside (PAN)-treated rats, human iPSC-derived podocytes, and kidney organoids. We first established that systemic administration of the TRPC5 inhibitor AC1903 was sufficient to protect podocyte cytoskeletal proteins and suppress proteinuria in PAN-induced nephrosis rats, an established model of podocyte injury. TRPC5 current was recorded in the human iPSC-derived podocytes and was blocked by AC1903. PAN treatment caused podocyte injury in human iPSC-derived podocytes and kidney organoids. Inhibition of TRPC5 channels reversed the effects of PAN-induced injury in human podocytes in both 2D and 3D culture systems. Taken together, these results revealed the relevance of TRPC5 channel inhibition in puromycin-aminonucleoside induced nephrosis models, highlighting the potential of this therapeutic strategy for patients.Keywords
This publication has 43 references indexed in Scilit:
- ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signalingJournal of Clinical Investigation, 2013
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- The role of the podocyte in albumin filtrationNature Reviews Nephrology, 2013
- Pathobiology of focal segmental glomerulosclerosisCurrent Opinion in Nephrology and Hypertension, 2012
- Cell Biology and Pathology of PodocytesAnnual Review of Physiology, 2012
- Focal Segmental GlomerulosclerosisNew England Journal of Medicine, 2011
- Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosisJournal of Clinical Investigation, 2011
- Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistanceBMC Nephrology, 2010
- NADPH Oxidase-derived ROS Contributes to Upregulation of TRPC6 Expression in Puromycin Aminonucleoside-induced Podocyte InjuryCellular Physiology and Biochemistry, 2009
- TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal functionNature Genetics, 2005